Drug Approval | October 02, 2024
SMS Pharma receives EDQM certification to supply Ibuprofen in Europe
The inspection conducted by EDQM at its Visakhapatnam facility
The inspection conducted by EDQM at its Visakhapatnam facility
Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market
_256_384.jpg)
The Indian companies that have been granted licences are Cipla, Sun Pharma, Laurus Labs, Divis Labs, Glenmark, Cadila, Torrent, Emcure, McLeods, SMS Pharmaceuticals, Strides, Biocon, Aurobindo Pharma, Hetero, Granules, Amneal, MSN, Arene Life Sciences and Viatris
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
Subscribe To Our Newsletter & Stay Updated
